These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29155144)
1. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs. Sömmer A; Sandner P; Behrends S Biochem Pharmacol; 2018 Jan; 147():10-20. PubMed ID: 29155144 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine 135 of the β Rühle A; Elgert C; Hahn MG; Sandner P; Behrends S Eur J Pharmacol; 2020 Aug; 881():173203. PubMed ID: 32446711 [TBL] [Abstract][Full Text] [Related]
3. Synergistic stabilisation of NOsGC by cinaciguat and non-hydrolysable nucleotides: Evidence for sGC activator-induced communication between the heme-binding and catalytic domains. Sömmer A; Behrends S Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):702-711. PubMed ID: 29653192 [TBL] [Abstract][Full Text] [Related]
4. A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGC. Elgert C; Rühle A; Sandner P; Behrends S Biochem Pharmacol; 2019 May; 163():142-153. PubMed ID: 30753814 [TBL] [Abstract][Full Text] [Related]
5. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway. Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808 [TBL] [Abstract][Full Text] [Related]
6. The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis. Baldissera L; Squebola-Cola DM; Calixto MC; Lima-Barbosa AP; Rennó AL; Anhê GF; Condino-Neto A; De Nucci G; Antunes E Pulm Pharmacol Ther; 2016 Dec; 41():86-95. PubMed ID: 27816773 [TBL] [Abstract][Full Text] [Related]
7. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size. Bice JS; Keim Y; Stasch JP; Baxter GF Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501 [TBL] [Abstract][Full Text] [Related]
8. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770. Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320 [TBL] [Abstract][Full Text] [Related]
9. Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery. Tawa M; Shimosato T; Sakonjo H; Masuoka T; Nishio M; Ishibashi T; Okamura T J Vasc Res; 2019; 56(3):109-116. PubMed ID: 31085923 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content. Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395 [TBL] [Abstract][Full Text] [Related]
11. Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes. Kumar V; Martin F; Hahn MG; Schaefer M; Stamler JS; Stasch JP; van den Akker F Biochemistry; 2013 May; 52(20):3601-8. PubMed ID: 23614626 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis. Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020 [TBL] [Abstract][Full Text] [Related]
13. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant. Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520 [TBL] [Abstract][Full Text] [Related]
14. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice. Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894 [TBL] [Abstract][Full Text] [Related]
15. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice. Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693 [TBL] [Abstract][Full Text] [Related]